Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

64.26
-0.7100-1.09%
Post-market: 64.260.00000.00%19:30 EDT
Volume:52.74K
Turnover:3.38M
Market Cap:91.56M
PE:- -
High:64.61
Open:64.61
Low:63.59
Close:64.97
52wk High:68.00
52wk Low:36.00
Shares:1.42M
Float Shares:1.42M
Volume Ratio:1.40
T/O Rate:3.70%
Dividend:0.65
Dividend Rate:1.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Insiders Shake Up Innovative, Alcoa, Illumina, Southern, Marathon

TIPRANKS
·
1 hour ago

S&P 500 Quarterly Shake-Up: AI Demand Propels Bloom Energy Into the Index, Alongside Illumina and Everpure

Stock News
·
10 hours ago

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P Smallcap 600

THOMSON REUTERS
·
14 hours ago

Illumina Director Keith Meister Disposes of USD 30.51 Million in Common Shares

Reuters
·
15 hours ago

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
15 hours ago

Guardant Health Announces Landmark FDA Approval of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Breast Cancer

THOMSON REUTERS
·
15 hours ago

S&P Dow Jones Indices: Bloom Energy, Illumina, and Everpure Set to Join S&P 500

THOMSON REUTERS
·
16 hours ago

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
17 hours ago

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Yesterday

Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02

Reuters
·
Yesterday

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Reuters
·
Yesterday

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

TIPRANKS
·
Yesterday

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones
·
Yesterday

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Dow Jones
·
Sep 03

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live
·
Sep 03

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

Reuters
·
Sep 03

uniQure seeks accelerated approval for Huntington’s gene therapy

TIPRANKS
·
Sep 02

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

GlobeNewswire
·
Sep 02

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Dow Jones
·
Sep 02

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032

Reuters
·
Sep 02